Comparison of Clinical and Biochemical Parameters in Atrial Fibrillation Patients Using Dabigatran and Rivoraxaban and Their Relationship with Complications

Journal Title: Istanbul Medical Journal - Year 2020, Vol 21, Issue 2

Abstract

Introduction: Atrial fibrillation (AF) is a common disease that increases mortality and morbidity. New generation oral anticoagulants (NOACs) are agents that reduce ischemic events in patients with AF. In this study, we aim to compare biochemical and clinical parameters and examine the risk factors for thrombotic complications (such as stroke, myocardial infarction, systemic embolization) in patients using NOACs (dabigatran and rivaroxaban). Methods: This study was designed as a retrospective, method development study. The study included 205 patients who were admitted to Emergency Service, Adıyaman University Training and Research Hospital, from January 2013 to December 2014. The patients were divided into two groups as rivaroxaban users and dabigatran users. The differences of laboratory parameters of patients before drug intake and during their emergency department visits were analyzed. [Δwhite blood cells, Δhemoglobin, Δhematocrit, Δplatelet, Δplatecrit, Δplatelet distribution width, mean platelet volume (ΔMPV)]. Results: There were no major differences between two groups in terms of CHA2DS2-VASc scores, complications and duration of drug intake. There was statistically significant decrease with regard to MPV (p<0.001), in both of the groups with the usage of NOACs. The optimal threshold point of ΔMPV in the prediction of the thrombotic complications was ≤0.7 fL, with 91.7% sensitivity and 62.2% specificity [area under the curve: 0.805, 95% confidence interval: 0.744-0.857, p<0.001). Conclusion: As a result, the detection of high CHA2DS2- VASc score for the patients with AF using NOACs and visiting emergency department and less volume decline in previous MPV value are simple parameters to be used for predicting thrombotic cases and will be clinically useful.

Authors and Affiliations

İrfan Aydın, Mehmet Kaan Poyraz, Abdullah Algın, Gökhan Aksel, Serkan Emre Eroğlu

Keywords

Related Articles

Intraoperative Neurophysiology Practice in the Surgical Treatment of Posterior Fossa Lesions: Cerrahpaşa Experience

Introduction: Posterior fossa surgery involves a risk of injury on a variety of critical neurological structures. Intraoperative neuromonitoring (IONM) has become a routine scrutiny with newly developed tests for sparing...

Overview of Patients with Multiple Primary Tumors During Eighty-four Months Follow-up: A Single Center Experience

Introduction: Advances in oncological diagnosis and treatment increase survival and remission of the disease. However, prolonged survival also increases the likelihood of developing second primary malignancies. The aim o...

Effects of Systemic Inflammatory Parameters on Mortality in Elderly Patients Admitted to Emergency Department with Abdominal Pain

Introduction: The aim of this study was to evaluate the prognostic value of systemic inflammatory markers, especially neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) in geriatric patients presenting...

Negative Impact of Postoperative Early Surgical Incision Dressing: A Prospective Observational Study

Introduction: Povidone-iodine (Betadine®) is a commonly used solution to prevent surgical site infection in the postoperative period. In this study, time of first dressing after surgery was investigated. Early (second da...

Prevalence and Clinical Importance of Coronary Artery Ectasia: Tertiary Center Experience

Introduction: The incidence, prognostic significance, clinical features and risk factors of coronary artery ectasia (CAE) in patients undergoing coronary angiography were investigated. Methods: A total of 10.320 coronar...

Download PDF file
  • EP ID EP685071
  • DOI 10.4274/imj.galenos.2020.32650
  • Views 105
  • Downloads 0

How To Cite

İrfan Aydın, Mehmet Kaan Poyraz, Abdullah Algın, Gökhan Aksel, Serkan Emre Eroğlu (2020). Comparison of Clinical and Biochemical Parameters in Atrial Fibrillation Patients Using Dabigatran and Rivoraxaban and Their Relationship with Complications. Istanbul Medical Journal, 21(2), -. https://europub.co.uk/articles/-A-685071